Creative Medical Technology Holdings, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CELZ, updated each market day.
CELZ AI Sentiment
AI predicts Creative Medical Technology Holdings, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Creative Medical Technology Holdings, Inc. Common Stock
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Sector
Exchange
Market Cap
$7,541,202
Cap Tier
Employees
4
Headquarters
PHOENIX, AZ
Listed Since
April 30, 2009
CELZ Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CELZ Volatility
Creative Medical Technology Holdings, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
